Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study.

PubWeight™: 2.60‹?› | Rank: Top 1%

🔗 View Article (PMC 2540432)

Published in BMJ on June 18, 1994

Authors

M M Breteler1, J J Claus, D E Grobbee, A Hofman

Author Affiliations

1: Department of Epidemiology, Erasmus University Medical School, Rotterdam, Netherlands.

Articles citing this

The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78

Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ (2010) 3.98

A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52

The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42

The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26

Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev (2008) 2.62

The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56

Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09

Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91

Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91

Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement. BMJ (2009) 1.89

Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ (2008) 1.77

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72

Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke (2009) 1.66

The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol (2015) 1.61

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59

Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects. J Neurol Neurosurg Psychiatry (2002) 1.52

Cognitive function in the oldest old: women perform better than men. J Neurol Neurosurg Psychiatry (2001) 1.44

Cognitive impairment and mortality in a cohort of elderly people. BMJ (1996) 1.35

Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry (2001) 1.30

Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology (2005) 1.30

Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort. J Epidemiol Community Health (1999) 1.30

Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc (2009) 1.22

Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging (2008) 1.19

Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging (2007) 1.18

Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10

A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences. Br J Gen Pract (1998) 1.10

Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: evidence from the Whitehall II study. Atherosclerosis (2007) 1.08

Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med (2009) 1.07

An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet (2009) 1.05

Cognitive function in the Caerphilly study: associations with age social class, education and mood. Eur J Epidemiol (1999) 1.05

Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. JAMA Neurol (2013) 1.04

Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02

Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: A randomized controlled trial. Psychopharmacology (Berl) (2011) 0.96

Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord (2010) 0.95

Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab (2013) 0.95

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open (2013) 0.91

Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp (2012) 0.91

Heart disease as a risk factor for dementia. Clin Epidemiol (2013) 0.89

Dietary fat intake in relation to cognitive change in high-risk women with cardiovascular disease or vascular factors. Eur J Clin Nutr (2010) 0.89

Gender, resources across the life course, and cognitive functioning in Egypt. Demography (2008) 0.89

Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol (2012) 0.88

Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease. Int J Geriatr Psychiatry (2009) 0.87

Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. J Biomed Biotechnol (2005) 0.87

Alcohol intake, carotid plaque, and cognition: the Northern Manhattan Study. Stroke (2006) 0.86

Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population. BMC Psychiatry (2010) 0.85

Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Alzheimers Res Ther (2010) 0.82

Retinal microvascular abnormalities and cognitive function in Latino adults in Los Angeles. Ophthalmic Epidemiol (2012) 0.81

Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. Contemp Clin Trials (2012) 0.80

Neuroprotective effects of garlic a review. Libyan J Med (2008) 0.79

Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics. Neurol Clin (2016) 0.78

Individual capital and cognitive ageing in Guatemala. Popul Stud (Camb) (2009) 0.78

Comorbidity and dementia: A nationwide survey in Taiwan. PLoS One (2017) 0.77

Optical imaging of resting-state functional connectivity in a novel arterial stiffness model. Biomed Opt Express (2013) 0.77

Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study. BMJ Open (2014) 0.76

Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging. J Alzheimers Dis (2015) 0.76

Cognitive function in patients undergoing coronary angiography. Heart Asia (2010) 0.76

Cognitive dysfunctions in intensive cardiac care unit. Indian J Psychiatry (2010) 0.76

NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study. Neurology (2014) 0.75

Atherosclerotic disease and cognitive decline. BMJ (1994) 0.75

Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients. Am J Kidney Dis (2017) 0.75

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol (2015) 0.75

Relation of cardiac ventricular repolarization and global cognitive performance in a community population. Am J Cardiol (2010) 0.75

The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK). BMC Psychol (2013) 0.75

Dietary patterns are associated with cognitive function in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. J Nutr Sci (2016) 0.75

Serum phosphorus levels and risk of incident dementia. PLoS One (2017) 0.75

Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes. Sci Rep (2017) 0.75

Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis. PLoS One (2017) 0.75

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Aging, natural death, and the compression of morbidity. N Engl J Med (1980) 17.40

The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32

Human aging: usual and successful. Science (1987) 8.43

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67

Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26

Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA (1987) 1.86

Preventable senility: a call for action against the vascular dementias. Lancet (1992) 1.80

Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol (1992) 1.74

Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis (1981) 1.52

Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci (1992) 1.46

A community-based study of dementia: the Rotterdam Elderly Study. Neuroepidemiology (1992) 1.33

Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer's type: a continuum? Lancet (1988) 1.19

The association of education and socioeconomic status with the Mini Mental State Examination and the clinical diagnosis of dementia in elderly people. Age Ageing (1990) 1.14

Articles by these authors

A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84

Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67

Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55

Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03

Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27

Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12

The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02

Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91

Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51

The epidemiology of heart failure. Eur Heart J (1997) 4.31

Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99

Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96

J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75

J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51

External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47

Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42

Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39

Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26

Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18

The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07

Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82

Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82

Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80

Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79

Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72

Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70

Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66

Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65

Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64

Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61

C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59

A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43

Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43

NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41

Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39

Decreased selenium levels in acute myocardial infarction. JAMA (1989) 2.36

Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med (2001) 2.35

Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology (2004) 2.35

A randomized trial of sodium intake and blood pressure in newborn infants. JAMA (1983) 2.32

Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31

Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31

Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31

Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30

Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28